FindTrial
Sign In

Strength training as a complementary treatment in the immune system of people living with HIV/Aids: clinical and randomized trial.

Effect between two methods of interval training of high intensity in the process Inflammation and subclinical atherosclerosis of people living with HIV/Aids: a study Double blind clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9znxcq
Enrollment
Unknown
Registered
2017-09-21
Start date
2017-03-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enfermedad por el virus de la inmunodeficiencia humana (HIV)

Interventions

Experimental group: 20 individuals living with HIV / AIDS, will perform strength training (60% to 90% of 1 maximal repetition of exercises), will be performed in a total of 36 bodybuilding sessions. C
Behavioural
G11.427.410.698.277
G11.427.410.698.277.187

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Individuals receiving the first antiretroviral regimen; undetectable viral load in the last six months; CD4+cell counts> 200 u/L in the last six months; use of antiretroviral therapy for more than six months; low risk of ischemic cardiac event Framingham; To have an adequate physical condition.

Exclusion criteria

Exclusion criteria: Disorders of locomotion; mental disorders, except anxiety and depression; continuous use of depressant drugs of the Central Nervous System (CNS), except benzodiazepine, use of statins, use of corticosteroids; use of non-hormonal anti-inflammatory drugs; pregnancy or breastfeeding; severe renal and / or hepatic and / or cardiopulmonary disease.

Design outcomes

Primary

MeasureTime frame
Increased anti-inflammatory cell level and low level of pro-inflammatory cells of the immune system of people living with HIV/Aids. It will be checked by flow cytometry. Where the measurements of each item will be performed three times, the first at the beginning of the project, the second after 18 sessions and the last after 36 training sessions.—

Secondary

MeasureTime frame
Increased muscle mass and decreased body fat level will be employed the technique of dual beam x-ray absorptiometry (DXA). As well as the decreased levels of fat in the blood (Atherosclerosis), which will be performed through the ultrasound of the carotid artery. Where the measurements of each item will be performed three times, the first at the beginning of the project, the second after 18 sessions and the last after 36 training sessions.—

Countries

Brazil

Contacts

Public ContactGustavo Barros

Universidade Federal de Pernambuco

gustavowillames@hotmail.com+55(81)996575159

Outcome results

None listed

Source: REBEC (via WHO ICTRP)